Initiation of extracorporeal photopheresis in lung transplant patients with mild to moderate refractory BOS: A single-center real-life experience.

Fiche publication

Date publication

mai 2022

Journal

Respiratory medicine and research

Auteurs

Membres identifiés du Cancéropôle Est :
Pr OLLAND Anne

Tous les auteurs :
Leroux J, Hirschi S, Essaydi A, Bohbot A, Degot T, Schuller A, Olland A, Kessler R, Renaud-Picard B

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35525096

Résumé

Bronchiolitis obliterans syndrome (BOS) is the main limitation to long-term survival following lung transplantation. Several studies generated promising results regarding the efficacy of extracorporeal photopheresis (ECP) in BOS management. We aimed to compare FEV1 evolution in ECP-treated versus non-ECP treated patients among BOS recipients.